Sign in

CIK 0001404281

  • Non-accelerated filer
  • Smaller reporting company

Eledon Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-238-8090
Business address
19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
Former names
Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy Director bought 8,000 shares at $5.74 ($45,920)
  9. 4 Option exercise President and CEO acquired 28,015 shares (option exercise)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy Director bought 3,000 shares at $11.25 ($33,750)
  16. 4 Open-market sale Chief Operating Officer sold 13,500 shares at $14.01 ($189,135)
  17. 4 Open-market sale Chief Financial Officer sold 4,668 shares at $13.13 ($61,291)
  18. 4 Open-market sale Chief Financial Officer sold 2,158 shares at $12.96 ($27,968)
  19. 4 Open-market sale President and CEO sold 12,564 shares at $13.70 ($172,127)
  20. 4 Option exercise President and CEO acquired 10,000 shares (option exercise)

Page 8 of 11 · 212 filings